Alzheimer's Disease

Questions discussed in this category

Is there a point at which further reduction in amyloid burden is no longer clinically meaningful or should the goal always be as much reduction as possible?

4 Answers available

How will you counsel patients regarding ARIA?

Do you see utility in trending serum neurofilament light chain levels or any alternative screening methods beyond MRI to help identify amyloid-related...

2 Answers available

Papers discussed in this category

JAMA, 2023 Jul 17

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.

Alzheimer's Disease

Questions discussed in this category

Papers discussed in this category

Related Topics